A randomized trial of multi-factorial primary prevention in high risk subjects candidate to a lung cancer early detection CT program
Key facts
- Where
- Milan, OlaszországSee the site
- Phase
- 2. fázis
Where in Olaszország
- Fondazione IRCCS - Istituto Nazionale dei TumoriMilan, OlaszországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione IRCCS Istituto Nazionale Dei Tumori
- Trial code
- EU 2024-513660-26-00
- Record updated
- 2026. augusztus 31.
- Original description
The main objective of the study is to evaluate the efficacy of multi-factor intervention in high risk subjects in terms of inflammatory inflammation.Read full original descriptionShow less
The main objective of the study is to evaluate the efficacy of multi-factor intervention in high risk subjects in terms of inflammatory inflammation.
Inclusion: Age between 55 and 75 years; Heavy smoker; Eligibility to screening with annual chest CT; Availability and ability to use the Internet via PC, tablet or smartphone; Ability to understand the project to which you intend to participate; No tumors in the last 5 years; Signature of informed consent for enrollment in the study and for the processing of personal data.
Exclusion: Chronic treatment with cardioASA, or other anti-clotting or anti-coagulant drugs (for example: heparin, dicumarol); Treatment with methotrexate; Serious psychiatric problems; History of asthma induced by the administration of salicylates or substances to similar activity, particularly non-steroidal antiinflammatory drugs; Gastroduodenal ulcer; Severe chronic pathology (eg: severe respiratory and / or renal and / or hepatic and / or cardiac insufficiency); Severe kidney failure; Hypersensitivity to acetylsalicylic acid, salicylates or any of the excipients (excipients: cellulose powder, corn starch; coating: copolymers of methacrylic acid, sodium lauryl sulfate, polysorbate 80, talc, triethyl citrate); Abuse of alcohol or other substances (even before); Existing Mastocytosis; Hemorrhagic diathesis.